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A transposon mutagenesis procedure functional in the gram-negative swine pathogen ActinobaciUus
pleuropneumoniae was developed for the first time. The technique involved the use of a suicide conjugative
plasmid, pLOF/Km, carrying a mini-TnlO with an isopropyl-o-D-thiogalactopyranoside (IPTG)-inducible
transposase located outside the mobile element (M. Herrero, V. de Lorenzo, and K. N. Timmis, J. Bacteriol.
172:6557-6567, 1990). The plasmid was mobilized from Escherichia coli to A. pleuropneumoniae through the
RP4-mediated broad-host-range conjugal transfer functions provided by the chromosome of the donor strain.
When IPTG was present in the mating medium, A. pleuropneumoniae CM5 transposon mutants were obtained
at a frequency of 10-i , while no mutants were detected in the absence of IPTG. Since the frequency of conjugal
transfer ofthe RP4 plasmid fromE. coli toA. pleuropneumoniae CM5 was found to be as low as 10-4, the above
result indicated that the expression level of the transposase was a critical factor for obtaining a workable
efficiency of transposon mutagenesis. The transposon insertions occurred at random, as determined by
Southern blotting of chromosomal DNA of randomly selected mutants and by the ability to generate mutants
defective for the selected phenotypes. Almost all the mutants analyzed resulted from a single insertion of the
TnlO element. About 1.2% of the mutants resulted from the cointegration of pLOF/Km into the A.
pleuropneumoniae chromosome. The applicability of this transposon mutagenesis system was verified on other
A. pleuropneumoniae strains of different serotypes. The usefulness of this transposon mutagenesis system in
genetic studies of-A. pleuropneumonwne is discussed.
The gram-negative, facultatively anaerobic, encapsulated
bacterium Actinobacillus pleuropneumoniae (formerly clas-
sified in the genus Haemophilus) is an important veterinary
pathogen of the Pasteurellaceae family (23, 32). It is the
etiologic agent of porcine pleuropneumonia, a highly conta-
gious respiratory infection causing heavy economic losses to
the swine industry (30, 38). Clinically, A. pleuropneumoniae
infection occurs as acute outbreaks of high mortality in 24 to
48 h or as chronic persistent infections. The latter are of
special concern because of their high prevalence and be-
cause they follow an insidious course, manifested by impair-
ment of the growth rates of pigs in the fattening units (30,
38).
Currently available vaccines to A. pleuropneumoniae are
empirical and are not satisfactory enough in controlling the
disease in porcine populations. The major drawbacks of
these vaccines include a lack of cross-protection between
serotypes (12 have been described to date [20, 31]) and
failure to prevent the spread of the chronic infection from
carriers (18, 36). As a first step in the development of new
efficient vaccines, considerable efforts and resources have
been invested in research on the pathogenic and immuno-
genic mechanisms ofA. pleuropneumoniae. Several putative
virulence factors have been investigated (19), such as the
serotype-specific capsular material (8, 19, 36), the lipopoly-
saccharide (2, 8), the surface proteins (33, 45), and the
cytolytic protein toxins responsible for the hemolytic phe-
* Corresponding author.
notype of A. pleuropneumoniae (9, 11, 12). The study of
these putative virulence factors has been approached by
means of purification and characterization techniques (2, 9,
11, 12, 45) and, in recent years, by gene cloning and
sequencing (5, 10, 13, 16, 28, 41). Although some experimen-
tal evidence indicating that these factors are involved in
virulence has been obtained (19, 21, 42), their exact role in
the pathogenicity of A. pleuropneumoniae has not been
assessed so far.
The analysis of mutants affected in the expression of
specific genes is perhaps the most powerful approach to
investigate the role and the mechanism of action of mole-
cules possibly involved in pathogenicity and virulence. To
date, only spontaneously occurring or chemically inducedA.
pleuropneumoniae mutants, defective in capsule or hemoly-
sin production, have been studied (1, 21, 22, 35). However,
since these mutants are not well characterized genetically (in
the sense that the kind and number of genetic determinants
affected remain unknown), virulence studies based on them
did not provide meaningful information. When genetic sys-
tems are not sufficiently developed for a certain bacterial
species, as is the case forA. pleuropneumoniae, transposon
mutagenesis could be a useful tool to generate well-charac-
terized insertion mutants. Although this approach has been
widely used in studies on the virulence of a number of
gram-negative and gram-positive pathogenic bacteria (14,
47), to our knowledge, transposon mutagenesis has not been
achieved in A. pleuropneumoniae. In this article, we de-
scribe a transposon mutagenesis system that allows the
generation, with suitable frequencies, of single, stable, and
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TABLE 1. Strains and plasmids used in this study
Strain or plasmid Description Source (reference)
E. coli
LE392 supF supE hsdR galK trpR metB lacY tonA V. de Lorenzo
CC118(Apir) A(ara-leu) araD AlacX74 galE galKphoA20 thi-1 rpsE rpoB argE(Am) recAI Apir V. de Lorenzo (17)
SMio(Apir) thi-1 thr leu tonA lacYsupE recA::RP4-2-TcT::Mu Km' Apir M. Simonet
S17-1(Apir) thi pro hsd(r- m+) recA::RP4-2-Tcr::Mu KmT::Tn7 TpT Smr Xpir V. de Lorenzo
A. pleuropneumoniaea
CM5 Serotype 1 S. Rosendal (34)
ATCC 27088 Serotype 1, reference strain (also known as Shope 4074) Collection'
ATCC 27089 Serotype 2, reference strain (also known as 1536) Collection
ATCC 27090 Serotype 3, reference strain (also known as 1421) Collection
ATCC 33377 Serotype 5a, reference strain (also known as K17) Collection
ATCC 33590 Serotype 6, reference strain (also known as Fem+) Collection
WF83 Serotype 7, reference strain R. Nielsen
405 Serotype 8, reference strain R. Nielsen
CVJ13261 Serotype 9, reference strain R. Nielsen
D13039 Serotype 10, reference strain R. Nielsen
56153 Serotype 11, reference strain R. Nielsen
G58 Serotype 7, clinical isolate Our laboratory (15)
G72 Serotype 4, clinical isolate Our laboratory (15)
Plasmids
RP4 V. de Lorenzo
pJM703.1::TnS oriR6K mobRP4 Apr, with TnS (TnS-based delivery plasmid) M. Simonet
pLOF/Km ApT (TnlO-based delivery plasmid, Kxn') V. de Lorenzo (17)
a Nalidixic acid-resistant spontaneous mutants were obtained from all these A. pleuropneumoniae strains.
b ATCC.
random insertional disruptions in the genome of this bacte-
rium.
Bacterial strains and plasmids. The bacteria and plasmids
used in this study are listed in Table 1. A. pleuropneumoniae
CM5 (serotype 1) (34), a strain that has been used in several
investigations on the virulence and immunogenic properties
of A. pleuropneumoniae (35, 36), was used to develop the
transposon mutagenesis system. This strain has no detect-
able plasmids, as determined by us (not shown) and others
(35). For mutagenesis experiments, spontaneously occurring
nalidixic acid-resistant mutants of the A. pleuropneumoniae
strains were obtained.
Culture media and growth conditions. Tryptic soy (TS)
broth and TS agar were used for routine cultures. For A.
pleuropneumoniae, these media were supplemented with 6
mg of yeast extract and 10 p,g of NAD (Sigma Chemical Co.)
per ml. Antibiotics were added to TS media as required at
the following concentrations: ampicillin, 150 ,ug/ml; kanamy-
cin, 50 ,ug/ml; tetracycline, 50 ;Lg/ml; and nalidixic acid, 60jig/ml. For tryptophan auxotrophy experiments, the chemi-
cally defined medium of Maudsley and Kadis (27) solidified
with 1.5% agar was used. This medium was modified to
contain the same concentration of NAD as described above
and was supplemented when appropriate with tryptophan
(50 pg/ml).
DNA techniques. Plasmid DNA was prepared by using a
kit from Stratagene (La Jolla, Calif.). Chromosomal DNA
was obtained fromA. pleuropneumoniae by a simplified lysis
procedure with proteinase K and sodium dodecyl sulfate
(SDS) (48). For Southern blots (43), chromosomal DNA was
digested with XhoI as indicated by the manufacturer (New
England BioLabs, Inc., Beverly, Mass.), electrophoretically
separated on 0.8% agarose gels, and transferred to a nitro-
cellulose filter (Schleicher & Schuell Inc., Dassel, Germany)
as previously described (37). The probe was pLOF/Km
radiolabelled by random priming (kit from Amersham Corp.,
Buckinghamshire, England) with [a-32P]dCTP (Amersham).
Hybridization was done under stringent conditions, as fol-
lows: prehybridization at 65°C for 4 h with 6x SSC (lx SSC
is 0.15 M NaCl plus 0.015 M sodium citrate)-0.5% SDS-
0.05% skim milk; hybridization overnight at 65°C in the same
solution but with only 0.1% SDS; two 30-min washes at
room temperature with 2x SSC-0.1% SDS; and two addi-
tional 45-min washes at 68°C in 0.2x SSC-0.1% SDS. Filters
were then exposed to Kodak X-Omat film (Eastman Kodak
Co., Rochester, N.Y.) for 24 h at -70°C with an amplifying
screen.
Conjugation and transposition in A. pkuropneumoniae.
Transposon mutagenesis in gram-negative bacteria other
than Escherichia coli is usually achieved with carrier plas-
mid vectors mobilizable by the conjugal properties of the
broad-host-range plasmid RP4 (39). Since there was scarce
information about the conjugal properties ofA. pleuropneu-
moniae, a first step in our investigation was the determina-
tion of the ability of the RP4 plasmid to transfer from E. coli
LE392 to A. pleuropneumoniae CM5. We observed that A.
pleuropneumoniae CM5 and E. coli conjugate, with a fre-
quency of RP4 mobilization in the range of 10' (Table 2).
RP4-mediated tetracycline resistance was not expressed in
A. pleuropneumoniae CM5, so conjugal transfer events were
selected with ampicillin and kanamycin.
The results obtained prompted us to approach transposon
mutagenesis in A. pleuropneumoniae by the use of plasmids
mobilizable through RP4-based conjugal transfer (29). We
first used the suicide plasmid pJM703.1::TnS, obtained by
M. Simonet and S. Falkow (40) from pJM703.1 (29), with E.
coli SM10(Apir) as the donor strain. pJM703.1 and its deriv-
atives replicate only in specific bacterial strains, used as
donors, producing the rr protein determined by the pir gene
from the plasmid R6K (29). Although this insertional muta-
genesis system has proven to be efficient for other bacteria,
such as Yersiniapseudotuberculosis (40) and Vibrio cholerae
(29), we have been unable to detect TnS transposition in A.
pleuropneumoniae CM5.
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TABLE 2. Conjugation and transposition experiments
in A. pleuropneumoniae CM5'
Donor strain Slcin Resistance(plasmid) Selection frequency
Noneb Kmr <5 x 10-8
LE392 (RP4) Apr Kmi 2 x 10-4
SM10 (pJM703.1::TnS) Kmr <5 x 10-8
S17-1 (pLOF/Km), with IPTG Kmr 1 x 10-5
S17-1 (pLOF/Km), without IPTG Kmr <5 x 10-8
a Plasmids were mobilized from E. coli donor strains to A. pleuropneumo-
niae by conjugal transfer by means of a filter mating technique, as described
previously (7). In brief, 100 ±1 each of overnight cultures of donor and
recipient strains were mixed in S ml of sterile 10 mM MgSO4 and then passed
through a Millipore type HA 0.45-ILm filter. Mating filters containing donor
and recipient bacteria were placed onto a TS agar plate (containing 100 ,M
IPTG when needed for ptac induction in the case of the Tn1O derivative).
After incubation at 37C for 8 h, the bacterial cells were suspended in sterile
0.05 M phosphate buffer (pH 7.4) containing 0.85% NaCI, and appropriate
dilutions were plated on the counterselecting medium. Frequencies were
determined as the ratio of recipient cells expressing plasmid or transposon
antibiotic markers to the total number of recipients.
b Unmated recipient. Resistance frequency corresponds to spontaneous
Kmr mutants.
Without prejudice that the frequency at which an element
transposes is dependent on a great number of factors acting
on the system, according to previously reported TnS trans-
position rates ranging from 10-5 to 10-6 (6), we can specu-
late that our negative results are due to the loss of efficiency
derived from the low frequency of RP4-mediated conjugal
transfer from E. coli to A. pleuropneumoniae CM5 (10-4)
(Table 2). Following this interpretation, the final efficiency
rate of mutagenesis (mobilization plus transposition) was so
low that TnS insertion mutants were undetectable in prac-
tice. In favor of this hypothesis is the fact that, in an identical
system involving donor strain E. coli SM10 and plasmid
pSUP2011, from which pJM703.1 is derived (29), the transfer
frequency of TnS into the Rhizobium meliloti genome was 5
X 10-5 per recipient, being 10-1 per recipient the rate of RP4
mobilization between the same bacteria (39). An additional
interpretation that might account for the lack of detection of
TnS insertion mutants is the fact that the kanamycin resis-
tance (Kmr) gene of TnS has been reported not to be
expressed in A. pleuropneumoniae (49).
In view of these problems, we decided to try another
conjugative suicide vector, pLOF/Km, constructed by Her-
rero et al. (17). This is a derivative of pGP704 (pJM703.1
with a polylinker) (29), containing an insert with a mini-TnlO
(which carries a Kmr cassette derived from Tn9O3) initially
designed by Way et al. (46). In the pLOFlKm TnlO-based
delivery system, the transposase gene of ISIOR is located
outside of, and provided in cis to, the mobile element. In
addition, the transposase gene is under the control of the
isopropyl-,-D-thiogalactopyranoside (IPTG)-inducible ptac
promoter (17), a strategy which could improve transposition
efficiency (Fig. 1). When this vector was conjugally trans-
ferred from E. coli S17-1(Xpir) toA. pleuropneumoniae CM5
in the presence of IPTG, we found transposition mutants
with an efficiency of 10-5 (Table 2). In contrast, when IPTG
was absent from the mating medium, no mutants were
detected, indicating that the transposase expression level is
a limiting factor for transposition of the TnlO element in the
system under study. This result is consistent with the fact
that in natural conditions (i.e., without overexpression of the
transposase) the ISIO transposition rate is reported to be
about 10-4 per element per generation (24), and supports the
pLOF/Km
E E
5 kb
Ptac ISIOR
1 kb
l
- 70bpTnlO ends
I I I I I
N X N Sf M
mob
RP4
FIG. 1. Design of pLOF/Km, the delivery system for the mini-
TnlO that is functional in A. pleuropneumoniae (adapted from
Herrero et al. [17], with permission). Restriction sites are indicated
(M, MluI; N, NotI; E, EcoRI; Sf, Sfil; X, XhoI). The unique SfiI site
can be used for the insertion of foreign DNA fragments to be
transposed. The XhoI site present in the mobile element can be used
for cloning the DNA region flanking the mini-TnlO insertion from
transposon mutants.
aforementioned argument explaining our failure in detecting
TnS mutants with the pJM703.1::TnS delivery system.
Mutagenesis of A. pleuropneumnonie CM5 with the TnlO
derivative. The transposition properties of the mini-TnlO/
Kmr in A. pleuropneumoniae were investigated further in
order to determine the usefulness of the system for inser-
tional mutagenesis in this bacterium. Cointegration of
pLOF/Km was determined by selecting for kanamycin resis-
tance (mini-TnlO) and ampicillin resistance (determined by
the suicide plasmid). We found cointegration rates of about
1%, e.g., 13 of 1,100 colonies were resistant to both antibi-
otics (1.2% of cointegrates). This frequency is lower than
that reported by Herrero et al. (17), who found 5% cointe-
grates with pLOF/Km in Pseudomonas putida, and is much
lower than the 35% found by other investigators (3) in
Proteus mirabilis with a mini-TnS delivery system also
derived from pGP704 (7, 29).
A critical parameter in evaluating a transposon mutagen-
esis system is the ability to produce single, random inser-
tions. To analyze these characteristics, chromosomal DNA
from 25 exconjugants from 25 independent mutagenesis
experiments was restricted with XhoI (which cuts at a
unique site in the Tn1O derivative) (Fig. 1) (17) and analyzed
by Southern blotting with pLOF/Km as the probe. Figure 2,
in which 19 of these mutants are shown, illustrates that
almost all the insertions were single and occurred at different
locations. Of the 25 mutants, the insertions in only 2 mapped
identically, and in another, a multiple insertion likely took
place (Fig. 2). These findings allow to assume that no
significant mini-TnlO hot spots occur in the A. pleuropneu-
moniae chromosome. This might be explained by the fact
that the TnlO derivative bears a mutant ISIO transposase
b m
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with a much lower degree of target site specificity than the
wild type (25). Since four of the six consensus base pairs of
the target sites of TnlO insertion are G-C pairs (25), the
relatively low G+C content of the A. pleuropneumoniae
genome (42%) (23, 32) may also contribute to explaining the
absence of significant hot spots.
The insertion randomness of the mini-TnlO was also
demonstrated by indirect evidence, as provided by the
ability to isolate mutants of selected phenotypes. For this
purpose, we assessed the frequency of auxotrophic depen-
dence on the amino acid tryptophan in a bank of mini-TnlO-
induced A. pleuropneumoniae mutants. In a prototypic
experiment carried out with 1,136 insertional mutants (ran-
domly selected from 10 different mutagenesis experiments),
4 of them were tryptophan auxotrophs. This represents a
frequency of about 0.35%, a result in agreement with data on
transposon-induced auxotrophic mutations in other bacteria
(3, 26). The production of mutants deficient in the expression
of other phenotypes was also tested. For instance, we
isolated seven nonhemolytic mutants of A. pleuropneumo-
niae (44), indicating that not only metabolic but also viru-
lence-associated genes could be insertionally disrupted by
the use of pLOF/Km.
Finally, we carried out experiments to determine the
stability of the transposon insertions. By a previously pub-
lished protocol (3), we subcultured 550 Kmr colonies, se-
lected randomly from five different transposition experi-
ments, three times on TS agar without antibiotics at 37°C for
24 h. After these three passages without selective pressure,
the colonies were cultured again on a medium containing
kanamycin. None of the 550 clones failed to grow, indicating
that the mini-TnlO insertions were stably maintained. This
result is consistent with the fact that the transposase gene is
absent from the mobile element (see above), providing
highly stable insertions even without antibiotic selection (17,
25).
Applicability of the mini-TnlO transposon mutagenesis sys-
tem to other A. pleuropneumoniae strains. In order to deter-
mine whether the transposon mutagenesis system described
in this article is of general applicability to the species A.
pleuropneumoniae, we carried out experiments with 12
additional strains representing different serotypes (Table 1).
We were able to obtain nalidixic acid-resistant spontaneous
mutants of all these A. pleuropneumoniae strains. With the
abovementioned E. coli donor strain, Kmr exconjugants
were found with frequencies ranging from 10-5 to 10-7
(Table 3). We failed to detect Kmr colonies for only 2 of the
12 strains we tested.
Concluding remarks. We have successfully developed, for
the first time, a transposon mutagenesis system that is
functional in A. pleuropneumoniae. This was achieved with
a suicide conjugative vector, pLOF/Km, designed by Her-
rero et al. (17), carrying a mini-TnlO delivery system. In our
hands, this vector has proven to be a useful tool for
generating single, random, and stable transposon insertions,
at a workable frequency, in the A. pleuropneumoniae ge-
nome. Since the transposable element in transposon-induced
mutants is physically linked to the mutated gene, the trans-
poson mutagenesis technique reported here will allow easy
identification of the genetic determinants involved in the
investigated phenotypes of A. pleuropneumoniae. For this
purpose, the drug resistance marker of the transposon could
also be used for the selection of recombinant clones carrying
the target region. Besides these general advantages of trans-
poson mutagenesis, specific benefits derived from the par-
ticular features of the vector we used have to be considered.
FIG. 2. Random insertion of the TnlO element in the A. pleuro-
pneumoniae CM5 chromosome, as determined by Southern blot
analysis. Chromosomal DNA from 19 kanamycin-resistant, ampicil-
lin-sensitive transconjugants of A. pleuropneumoniae (from inde-
pendent transposition experiments; see text) was digested with
XhoI, electrophoresed on an agarose gel, transferred to a nylon
membrane, and hybridized with a radioactive probe prepared with
pLOF/Km to detect DNA fragments containing mini-TnlO inser-
tions. Since there was a unique XhoI site internal to the mini-TnlO
element, single-insertion mutants should lead to two reactive bands
in the Southern blot hybridization. The figure shows that most of the
mutants have single insertions of the mini-TnlO, mapping at different
sites. Lanes 3 and 7 correspond to mutants with mini-TnlO inser-
tions mapping at similar or identical locations. Lane 14 most likely
corresponds to a mutant with multiple insertions of the minitrans-
poson.
First, pLOF vectors carry a minitransposon which has
important advantages over classical transposable elements
(25). Since the transposase gene is located outside the
minitransposon, the mobile element does not undergo sec-
ondary transposition events, and thus the insertions gener-
ated are highly stable. On the other hand, a smaller mini-
transposon is more manageable, it transposes with an
increased efficiency, and, once inserted, it is less subject to
rearrangements with adjacent regions (25). Second, the
presence of unique NotI or Sfil sites internal to the mobile
element (17) allows, conjointly with the use of the auxiliary
cloning plasmids pUC18Not and pUC18Sfi (specifically con-
structed for this purpose) (17), the introduction of modified
or foreign genes into the genome of the mutated A. pleuro-
pneumoniae strain. Third, the modular conception of the
mobile element in pLOF vectors (17) enables the replace-
ment of the selection marker. This constitutes an important
application which allows the use of nonantibiotic markers
(e.g., resistance cassettes to the herbicide bialaphos, to
arsenite or mercuric salts, or to organomercurial compounds
[17]), opening the possibility of environmental release of the
genetically engineered strain, e.g., in the case of a live
J. BACTERIOL.
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TABLE 3. Transposon mutagenesis of different
A. pleuropneumoniae strains using pLOF/Kma
Recipient strain Frequency of Kmrexconjugants
ATCC 27088 1.2 x 10-6
ATCC 27089 1.3 x 10-5
ATCC 27090 NDb
ATCC 33377 1.1 x 10-6
ATCC 33590 2.5 x 10-6
WF83 1.6 x 10-6
405 1.0 x 10-7
CVJ13261 1.4 x 10-6
D13039 3.0 x 10-7
56153 2.0 x 10-7
G58 ND
G72 3.3 x 10-6
a Matings were performed and frequencies were determined as indicated in
Table 2, footnote a.
I ND, not detected.
vaccine. Finally, the possibility of replacing the selection
marker and the fact that recipient cells are not immune to
new transposition runs because of the lack of the trans-
posase permit multiple transposon insertions in the same
strain (17).
In conclusion, because of the enormous utility of inser-
tional mutagenesis with transposons in genetic studies of
bacteria (4), the availability of such a system for A. pleuro-
pneumoniae will contribute greatly to the development of
research on molecular aspects of the structure, metabolism,
physiology, and virulence of this pathogenic bacterium.
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